Standout Papers

YAP/TAZ and ATF4 drive resistance to Sorafenib in hepatocellular carcinoma by preventing ferroptosis 2021 2026 2022 2024331
  1. YAP/TAZ and ATF4 drive resistance to Sorafenib in hepatocellular carcinoma by preventing ferroptosis (2021)
    Ruize Gao, Ravi Kiran Reddy Kalathur et al. EMBO Molecular Medicine
  2. Arginine reprograms metabolism in liver cancer via RBM39 (2023)
    Dirk Mossmann, Christoph Müller et al. Cell
  3. Bipotent transitional liver progenitor cells contribute to liver regeneration (2023)
    Wenjuan Pu, Huan Zhu et al. Nature Genetics

Immediate Impact

54 standout
Sub-graph 1 of 22

Citing Papers

Lactate controls cancer stemness and plasticity through epigenetic regulation
2025 Standout
Tailoring traditional Chinese medicine in cancer therapy
2025 Standout
3 intermediate papers

Works of Caner Ercan being referenced

Patient-derived tumor organoids for personalized medicine in a patient with rare hepatocellular carcinoma with neuroendocrine differentiation: a case report
2022
YAP/TAZ and ATF4 drive resistance to Sorafenib in hepatocellular carcinoma by preventing ferroptosis
2021 Standout

Author Peers

Author Last Decade Papers Cites
Caner Ercan 501 167 353 297 22 832
Zongzhen Xu 459 185 419 225 25 779
Karthik Sekar 486 113 300 201 17 706
Jinghan Zhu 463 139 314 255 29 826
So Mee Kwon 490 198 327 132 29 847
Tingdong Yu 427 188 341 173 43 726
Peter Schirmacher 388 182 314 238 20 833
Haijian Zhang 558 141 327 128 48 791
Xiaohu Zhou 531 259 314 142 38 945
Sujatha Jagadeeswaran 457 357 196 166 16 959
Zeribe C. Nwosu 445 195 282 100 22 831

All Works

Loading papers...

Rankless by CCL
2026